Park West Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Park West Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,112,383	Closed	-$12.4M	–	183
2021 Q1	$12.4M	Buy	1,112,383 +159,192	+17%	+$1.68M	0.38%	70
2020 Q4	$10.9M	Buy	+953,191	New	+$10.4M	0.22%	77
2018 Q4	–	Sell	-1,426,764	Closed	-$22.1M	–	100
2018 Q3	$22.1M	Buy	1,426,764 +462,082	+48%	+$7.3M	0.8%	41
2018 Q2	$15.4M	Buy	964,682 +211,754	+28%	+$3.13M	0.58%	57
2018 Q1	$9.73M	Buy	752,928 +19,862	+3%	+$248K	0.43%	56
2017 Q4	$9.2M	Buy	+733,066	New	+$9.57M	0.42%	55

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Park West Asset Management's IRWD Position: Q2 2021 in Review

Park West Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 1,112,383 shares — an estimated $12.4M sold.

Park West Asset Management first reported a position in IRWD in Q4 2017 and held it in 6 quarters. The position peaked at $22.1M in Q3 2018. 209 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

Park West Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Park West Asset Management sold 1,112,383 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $12.4M.
Park West Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2017 and held it in 6 quarters.
Park West Asset Management's Ironwood Pharmaceuticals position peaked at $22.1M in Q3 2018.
209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Park West Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.